NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Global Vision, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Quality Design to Exhibit QCanywhere Proofreading Solutions at FCE Pharma 2013 - QCanywhere Industry Leading cloud-based inspection solutions to be showcased at FCE Pharma 2013 - GQD.com.br / QCanywhere.com
Global Quality Design to Exhibit QCanywhere Proofreading Solutions at FCE Pharma 2013

 

NewswireTODAY - /newswire/ - Montréal, Québec, Canada, 2013/05/02 - QCanywhere Industry Leading cloud-based inspection solutions to be showcased at FCE Pharma 2013 - GQD.com.br / QCanywhere.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Global Quality Design (GQD), an industry leader the distribution of products for the pharmaceutical and food markets, today announced its participation at FCE Pharma 2013, May 14 -16 at the Transamerica Expo Center (TEC) in Santo Amaro São Paulo, Brazil Booth #C151.

At this year's event, GQD is set to showcase the Global Vision extensive line of award-winning automated proofreading solutions, including the latest release of of its cutting-edge print and artwork inspection software - Digital-Page / ScanTVS Version 3.0.0.

The company will also spotlight QCanywhere cloud-based document, print and artwork inspection solutions. QCanywhere is a cloud-based business application bundle (QCapps) that is simple to access from any device. Designed for brand owners and professionals across multiple industries such as Printing, Graphic Arts, Financial, Legal, Healthcare and Pharmaceutical, these apps enable businesses to inspect documents regardless of geographic location. Reports can be generated and shared by e-mail to collaborate on quality and dramatically reduce approval cycles and time-to-market.

Join the QCanywhere Revolution
GQD is offering a free 15 day trial of QCanywhere
Please visit QCanywhere.com use promo code: QC15GQD

Commenting on GQD’s participation at FCE Pharma 2013, Mr. Alexandre Victoriano Gomes, CEO at Global Quality Design, said: “South America has become an important market segment for proofreading, and FCE Pharma is a perfect venue to showcase our latest ground-breaking Proofreading technologies. Our focus, as always, is about providing reliable, quality and affordable solutions that offer functionality and usability.”

About Global Quality Design
Global Quality Global Design (gqd.com.br) is a Global and Pioneer company specialized in Service and Solutions for Pharmaceutical, Hospital, Correlate, Nutrition, Cosmetics, Food and Consumer, providing full assistance under the current laws of Brazil, INMETRO, Countries of MERCOSUR, Andean, Central America and Mexico.

Global Quality Design offers the most complete Service and Product for your Company

About QCanywhere
QCanywhere (qcanywhere.com) is a cloud-based business application bundle (QCapps™) that is simple to access from any device. It is the first cloud-based solution for Quality Control of text, artwork, Braille, barcodes and print.

Available QCapps
QCtext Compare documents
QCartwork Compare artwork files
QCspell Spell check PDFs
QCbraille Translate Braille
QCprint Inspect printed materials
QCbarcode Inspect and grade barcodes

About Global Vision
Global Vision (globalvisioninc.com) is the world leader in the design and delivery of automated proofreading solutions. Its complete suite of advanced solutions featuring text-based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork, text verification, and text comparison related errors, providing end-to-end security at every stage of the workflow process.

Global Vision solutions are widely interoperable and have received commercial endorsement from the world’s leading Pharmaceutical, Consumer Packaged Goods (CPG), and Artwork Management companies.

Headquartered in Montreal, Canada, Global Vision has worldwide representation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Global Vision, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Global Quality Design to Exhibit QCanywhere Proofreading Solutions at FCE Pharma 2013

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Press Office - QCanywhere.com 
514-624-4422 mspooner[.]globalvisioninc.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Global Vision, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Global Vision, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development
Immunology Consultants Laboratory Rebrand Highlights R&D and Service Specializations
Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer At AACR 2024
Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
ONO Implements Oracle's CTMS for Global Centralized Management of Clinical Trials
BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors
Bruker Completes Acquisition of Optical Cell Imaging Company Phasefocus
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
SCHOTT Pharma Offers Complete Testing Suite for Container Selection and Drug Submission Preparation
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company
Ipsen’s Onivyde® Regimen, A Potential New Standard-of-care First-line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
Frost & Sullivan and Trautec have Conducted An Extensive Investigation Across the Recombinant Type XVII Collagen Industry Chain
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)